Serum visfatin levels in late pregnancy and pre-eclampsia

Acta Obstetricia et Gynecologica Scandinavica

Volumn 87, Issue 4, 2008, Pages 413-418

  Hu, Wensheng ^a   Wang, Zhengping ^a   Wang, Hanzhi ^a,b   Huang, Hefeng ^a,b   Dong, Minyue ^a,b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Key Laboratory of Women's Reproductive Health of Zhejiang Province   (China)

Author keywords

Adipokine; Insulin resistance; Pre eclampsia; Pregnancy; Visfatin

Indexed keywords

ADIPOCYTOKINE; VISFATIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INSULIN RESISTANCE; MEASUREMENT; METABOLIC DISORDER; OUTCOME ASSESSMENT; PATHOGENESIS; PREECLAMPSIA; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THIRD TRIMESTER PREGNANCY;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, THIRD;

EID: 41649118423     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340801976012     Document Type: Article

References (37)

1. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592-4.
2. Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension. 2005;46(6):1243-9.
3. Solomon CG, Seely EW. Brief review: hypertension in pregnancy: a manifestation of the insulin resistance syndrome? Hypertension. 2001;37(2):232-9.
4. Lu D, Yang X, Wu Y, Wang H, Huang H, Dong M. Serum adiponectin, leptin and soluble leptin receptor in pre-eclampsia. Int J Gynaecol Obstet. 2006;95(2):121-6.
5. O'Sullivan AJ, Kriketos AD, Martin A, Brown MA. Serum adiponectin levels in normal and hypertensive pregnancy. Hypertens Pregnancy. 2006;25(3):193-203.
6. Catalano PM, Hoegh M, Minium J, Huston-Presley L, Bernard S, Kalhan S, et al. Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia. 2006;49(7):1677-85.
7. Cortelazzi D, Corbetta S, Ronzoni S, Pelle F, Marconi A, Cozzi V, et al. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol (Oxf). 2007;66(3):447-53.
8. Haugen F, Ranheim T, Harsem NK, Lips E, Staff AC, Drevon CA. Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression. Am J Physiol Endocrinol Metab. 2006;290(2):E326-33.
9. Kajantie E, Kaaja R, Ylikorkala O, Andersson S, Laivuori H. Adiponectin concentrations in maternal serum: elevated in preeclampsia but unrelated to insulin sensitivity. J Soc Gynecol Invest. 2005;12(6):433-9.
10. Odden N, Henriksen T, Holter E, Grete Skar A, Tjade T, Morkrid L. Serum adiponectin concentration prior to clinical onset of preeclampsia. Hypertens Pregnancy. 2006;25(2):129-42.
11. Chen D, Dong M, Fang Q, He J, Wang Z, Yang X. Alterations of serum resistin in normal pregnancy and pre-eclampsia. Clin Sci (Lond). 2005;108(1):81-4.
12. Yura S, Sagawa N, Itoh H, Kakui K, Nuamah MA, Korita D, et al. Resistin is expressed in the human placenta. J Clin Endocrinol Metab. 2003;88(3):1394-7.
13. Palik E, Baranyi E, Melczer Z, Audikovszky M, Szocs A, Winkler G, et al. Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance. Diabetes Res Clin Pract. 2007;76(3):351-7.
14. Stephens JM, Vidal-Puig AJ. An update on visfatin/pre-B cell colony-enhancing factor, a ubiquitously expressed, illusive cytokine that is regulated in obesity. Curr Opin Lipidol. 2006;17(2):128-31.
15. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307(5708):426-30.
16. Berndt J, Kloting N, Kralisch S, Kovacs P, Fasshauer M, Schon MR, et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes. 2005;54(10):2911-6.
17. Lopez-Bermejo A, Chico-Julia B, Fernandez-Balsells M, Recasens M, Esteve E, Casamitjana R, et al. Serum visfatin increases with progressive beta-cell deterioration. Diabetes. 2006;55(10):2871-5.
18. Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ, et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2006;91(1):295-9.
19. Pagano C, Pilon C, Olivieri M, Mason P, Fabris R, Serra R, et al. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab. 2006;91(8):3165-70.
20. Haider DG, Schindler K, Schaller G, Prager G, Wolzt M, Ludvik B. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab. 2006;91(4):1578-81.
21. Krzyzanowska K, Krugluger W, Mittermayer F, Rahman R, Haider D, Shnawa N, et al. Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci (Lond). 2006;110(5):605-9.
22. Chan TF, Chen YL, Lee CH, Chou FH, Wu LC, Jong SB, et al. Decreased plasma visfatin concentrations in women with gestational diabetes mellitus. J Soc Gynecol Invest. 2006;13(5):364-7.
23. Dogru T, Sonmez A, Tasci I, Bozoglu E, Yilmaz MI, Genc H, et al. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract. 2007;76(1):24-9.
24. Li L, Yang G, Li Q, Tang Y, Yang M, Yang H, et al. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes. 2006;114(10):544-8.
25. Jian WX, Luo TH, Gu YY, Zhang HL, Zheng S, Dai M, et al. The visfatin gene is associated with glucose and lipid metabolism in a Chinese population. Diabetes Med. 2006;23(9):967-73.
26. ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. No. 33, January 2002. Obstet Gynecol. 2002;99(1):159-67.
27. Sagawa N, Yura S, Itoh H, Mise H, Kakui K, Korita D, et al. Role of leptin in pregnancy - a review. Placenta. 2002;23 Suppl A:S80-6.
28. Atawi FA, Warsy AS, Babay Z, Addar M. Leptin concentration during different stages of pregnancy. Clin Exp Obstet Gynecol. 2004;31(3):211-6.
29. Hauguel-de Mouzon S, Lepercq J, Catalano P. The known and unknown of leptin in pregnancy. Am J Obstet Gynecol. 2006;194(6):1537-45.
30. Hendler I, Blackwell SC, Mehta SH, Whitty JE, Russell E, Sorokin Y, et al. The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia. Am J Obstet Gynecol. 2005;193(3 Pt 2):979-83.
31. Highman TJ, Friedman JE, Huston LP, Wong WW, Catalano PM. Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy. Am J Obstet Gynecol. 1998;178(5):1010-5.
32. Baksu A, Ozkan A, Goker N, Baksu B, Uluocak A. Serum leptin levels in preeclamptic pregnant women: relationship to thyroid-stimulating hormone, body mass index, and proteinuria. Am J Perinatol. 2005;22(3):161-4.
33. Ramsay JE, Jamieson N, Greer IA, Sattar N. Paradoxical elevation in adiponectin concentrations in women with preeclampsia. Hypertension. 2003;42(5):891-4.
34. Mazaki-Tovi S, Kanety H, Sivan E. Adiponectin and human pregnancy. Curr Diabetes Rep. 2005;5(4):278-81.
35. Aka N, Atalay S, Sayharman S, Kilic D, Kose G, Kucukozkan T. Leptin and leptin receptor levels in pregnant women with hyperemesis gravidarum. Aust N Z J Obstet Gynaecol. 2006;46(4):274-7.
36. Henson MC, Castracane VD. Leptin in pregnancy: an update. Biol Reprod. 2006;74(2):218-29.
37. Fasshauer M, Bluher M, Stumvoll M, Tonessen P, Faber R, Stepan H. Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function. Clin Endocrinol (Oxf). 2007;66(3):434-9.